Teleflex Incorporated announced the completion of its previously announced acquisition of Vascular Solutions, Inc. On December 2, 2016, the two companies announced a definitive agreement for Teleflex to acquire all of the issued and outstanding shares of Vascular Solutions common stock for $56.00 per share, in cash.
Vascular Solutions is an innovative medical device company that focuses on developing clinical solutions for minimally invasive coronary and peripheral vascular procedures. As previously announced, the combination is expected to meaningfully accelerate the growth of Teleflex’s vascular and interventional businesses by its entry into the coronary and peripheral vascular market, as well as increased cross-portfolio selling opportunities to both Teleflex and Vascular Solutions customer bases.
Teleflex will provide additional details on the transaction, including an update to its fiscal year 2017 financial outlook as a result of this transaction, on its fourth quarter and full year 2016 investor conference call. The call will be held at 8:00 a.m. (ET) on Thursday, February 23, 2017. The call can be accessed through a live audio webcast on the company’s website, www.teleflex.com. An audio replay of the call will also be available on the website from February 23, 2017 at 11:00 a.m. (ET) to February 28, 2017 at 11:59 p.m. (ET) by calling 855-859-2056 (U.S./Canada) or 404-537-3406 (International), Passcode: 65576607.
